about
Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interactionSynthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptorMolecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.Protective effects of 2-deoxy-D-glucose on nephrotoxicity induced by cyclosporine A in ratsStructural mechanisms of cyclophilin D-dependent control of the mitochondrial permeability transition pore.Cardiopulmonary allotransplantation, a collective review: experimental progress and current clinical status.A fascinating journey into history: exploration of the world of isonitriles en route to complex amidesEuryjanicins E-G, poly-phenylalanine and poly-proline cyclic heptapeptides from the Caribbean sponge Prosuberites laughlini.Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.Protection against Cyclosporine-Induced Reprotoxicity by Satureja khuzestanica Essential Oil in Male Rats.Molecular mediators of mesenchymal stem cell biology.In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy.Total synthesis of cyclosporine: access to N-methylated peptides via isonitrile coupling reactions.Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites.Solid-phase enrichment and analysis of electrophilic natural productsUnfolding of CPR3 Gets Initiated at the Active Site and Proceeds via Two Intermediates.Estrogen receptor beta modulates permeability transition in brain mitochondria.
P2860
Q31046491-DDE8F60D-D51C-49BB-8179-251595FBEE13Q33317443-0F6782F0-18F8-47CA-A920-2482696E4582Q33772181-9B4B1311-7F85-4ECA-83C1-55B4FFC5F311Q34121284-206C23FB-3180-45D1-BAF8-B513ECEB2C8BQ35602894-EF07DD51-256F-4685-BA4E-28B81F9AFDA3Q35822853-861D216B-B7A4-4744-A0B9-7F3C3D2A47FEQ36131535-E2E30105-F6A4-4DEC-A2D4-B56B4422256DQ36175789-844845AB-3DEC-402A-9362-D2F00700D0D4Q36253534-A128F388-9202-4AC7-8642-9BF64AD39BE7Q36690840-40E8EDF1-F6AA-44A5-9411-043B2249BE70Q37962744-C3A4FD4C-8C4F-4EE3-B3C6-349EE8155EA4Q39399171-91FB8E56-3E97-458D-AD4D-EA5C4D329D18Q39781344-4EC6DE96-03A6-4BAD-BB2B-271A580DF686Q41874828-1A1C656B-D4AA-4ADD-A5C8-9CACCBDE7336Q42046845-55E1E89C-F70A-413C-A06D-D971BF8E3924Q51113683-E00C4A61-4468-4B7B-B473-BD366E3C7B45Q53836881-8F2740B8-5454-4520-BAAF-53CB8722CB37
P2860
description
1982 nî lūn-bûn
@nan
1982 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Cyclosporin A: a powerful immunosuppressant
@ast
Cyclosporin A: a powerful immunosuppressant
@en
Cyclosporin A: a powerful immunosuppressant
@nl
type
label
Cyclosporin A: a powerful immunosuppressant
@ast
Cyclosporin A: a powerful immunosuppressant
@en
Cyclosporin A: a powerful immunosuppressant
@nl
prefLabel
Cyclosporin A: a powerful immunosuppressant
@ast
Cyclosporin A: a powerful immunosuppressant
@en
Cyclosporin A: a powerful immunosuppressant
@nl
P2093
P2860
P1476
Cyclosporin A: a powerful immunosuppressant
@en
P2093
P2860
P304
P407
P577
1982-05-01T00:00:00Z